Relypsa

Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases.

Business Model:

Revenue: $20.9M

Employees: 201-500

Detailed Relypsa Information

Relypsa was acquired by Galenica.
The acquisition happend on 2016-07-21.
Details of the transaction were not public

Acquirer

Geographic Data

Relypsa headquarters map

Address: 100 Cardinal Way

City: Redwood City

State: CA

Zip: 94063

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$150M

Raised Total:

$447M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases.

Contact Phone:
+16504219500

Contact Email:

Relypsa went public on 11/15/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/15/2013

Ticker Symbol:
RLYP

IPO Price:
$11/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2013 IPO $75.3M
5/2010 Debt Financing $4M
6/2014 Post-IPO Debt 2 $35M Oxford Finance LLC
Silicon Valley Bank
Oxford Finance LLC
Silicon Valley Bank
10/2007 Series A 6 $33M Sprout Group
New Leaf Venture Partners
Mediphase Venture Partners
Delphi Ventures
CMEA Capital
5AM Ventures
2/2015 Post-IPO Equity $149.5M
7/2012 Private Equity Round $0 5AM Ventures
Delphi Ventures
Mediphase Venture Partners
New Leaf Venture Partners
OrbiMed
Sibling Capital
Sprout Group
5AM Ventures
Delphi Ventures
Mediphase Venture Partners
New Leaf Venture Partners
OrbiMed
Sibling Capital
Sprout Group
9/2010 Series B 6 $70M OrbiMed
5AM Ventures
Delphi Ventures
Mediphase Venture Partners
New Leaf Venture Partners
Sprout Group
OrbiMed
10/2012 Venture Round 3 $2.6M OrbiMed
5AM Ventures
New Leaf Venture Partners
OrbiMed
5AM Ventures
New Leaf Venture Partners
8/2011 Series B 6 $70.1M OrbiMed
5AM Ventures
Delphi Ventures
Mediphase Venture Partners
New Leaf Venture Partners
Sprout Group
OrbiMed
8/2012 Series C $0 New Leaf Venture Partners
Delphi Ventures
Sibling Capital
Sprout Group
Mediphase Venture Partners
5AM Ventures
OrbiMed
New Leaf Venture Partners
Delphi Ventures
Sibling Capital
Sprout Group
Mediphase Venture Partners
5AM Ventures
OrbiMed
5/2016 Post-IPO Debt $150M
8/2012 Series C 7 $80M OrbiMed Advisors, LLC
New Leaf Venture Partners
5AM Ventures
Delphi Ventures
Sprout Group
Mediphase Venture Partners
Sibling Capital, LLC
New Leaf Venture Partners
Delphi Ventures
Sibling Capital
Sprout Group
Mediphase Venture Partners
7/2012 Private Equity Round 7 $62.4M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research